Ocular Therapeutix Appoints David W. Robinson as Global Chief Commercial Officer
Position
Chief Commercial Officer
Company
Ocular Therapeutix
BedfordBiotechnologyHealth CareTherapeuticsPharmaceuticalDescription
Ocular Therapeutix has appointed David W. Robinson as Global Chief Commercial Officer. His extensive background in retina drug launches positions the company favorably for the global launch of AXPAXLI, pending approval.
Quick answer
Ocular Therapeutix Appoints David W. Robinson as Global Chief Commercial Officer (January 21, 2026). Ocular Therapeutix is based in Bedford, Massachusetts, United States.
- Who is the new Chief Commercial Officer at Ocular Therapeutix?
- Ocular Therapeutix named David W. Robinson Chief Commercial Officer, announced January 21, 2026.
- What did Ocular Therapeutix announce on January 21, 2026?
- Ocular Therapeutix has appointed David W. Robinson as Global Chief Commercial Officer. His extensive background in retina drug launches positions the company favorably for the global launch of AXPAXLI, pending approval.
- What does Ocular Therapeutix do?
- Ocular Therapeutix, Inc. is a biopharmaceutical company committed to redefining the retina experience across drug development, treatment, and outcomes.
- Where is Ocular Therapeutix based?
- Ocular Therapeutix is based in Bedford, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Bicycle Therapeutics (February 3, 2026), LeonaBio, Inc. (February 3, 2026), Mezzion Pharma (January 6, 2026) and NuCana (January 6, 2026) also announced leadership changes within 45 days of Ocular Therapeutix.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Bicycle Therapeutics Appoints Travis Thompson as Chief Executive Officer (February 3, 2026)
- LeonaBio Appoints Mark F. Kubik as Chief Business Officer (February 3, 2026)
- Mezzion Pharmaceuticals Appoints Ridwan Shabsigh as President and COO (January 6, 2026)
- NuCana Appoints Theresa Bruce as Chief Operating Officer (January 6, 2026)
- Bristol Myers Squibb Appoints Harald Hampel as Senior VP Worldwide Head of Medical Affairs. (February 9, 2026)
- Aquestive Therapeutics Appoints Dr. Matthew Greenhawt as Chief Medical Officer (February 18, 2026)
Who to call at Ocular Therapeutix, and when
A new leader at Ocular Therapeutix brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Ocular Therapeutix raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ocular Therapeutix, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ocular Therapeutix. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ocular Therapeutix changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Ocular Therapeutix changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.